Verasense
Payments companies reported to CMS as associated with Verasense. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Verasense, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Verasense
These are the largest totals companies reported as associated with Verasense. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Martin Roche | Ft. Lauderdale, FL | Orthopaedic Surgery | $12,750.00 |
| David Howe | Winston Salem, NC | Orthopaedic Surgery | $12,000.00 |
| Geoffrey Van Flandern | Waltham, MA | Orthopaedic Surgery | $8,500.00 |
| John Wright | Kearney, NE | Orthopaedic Surgery | $8,495.79 |
| Cory Calendine | Franklin, TN | Adult Reconstructive Orthopaedic Surgery | $5,600.00 |
| Alejandro Gonzalez Della Valle | New York, NY | Orthopaedic Surgery | $3,848.84 |
| Charles Haggerty | Wasilla, AK | Orthopaedic Surgery | $3,300.00 |
| Chance Moore | San Antonio, TX | Orthopaedic Surgery | $1,200.00 |
| Paul Jacob | Oklahoma City, OK | Adult Reconstructive Orthopaedic Surgery | $500.00 |
| Elvis Grandic | Boynton Beach, FL | Adult Reconstructive Orthopaedic Surgery | $267.72 |
Prescribed Verasense?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.